Overview

lenalidomide


'lenalidomide' can also refer to...

lenalidomide

lenalidomide n.

Reversible Fanconi syndrome due to lenalidomide

Kidney dysfunction during lenalidomide treatment for AL amyloidosis

A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma

O2–038LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma

P11.05LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

Rapid Resolution of Mycobacterium marinum Chronic Skin Infection during Lenalidomide Therapy for Chronic Lymphocytic Leukemia

Clinical experience with lenalidomide alone or in combination with rituximab in indolent B-cell and mantle cell lymphomas

A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy

P06.01A DOSE ESCALATION STUDY OF IBRUTINIB WITH LENALIDOMIDE FOR RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA

O2–070A CASE OF PRIMARY PLASMA CELL LEUKEMIA WITH A FAVORABLE RESPONSE TO RETREATMENT WITH LENALIDOMIDE AND DEXAMETHASONE

O2–073INCIDENCE OF DEEP VEIN THROMBOSIS (DVE) IN MYELOMA PATIENTS TREATED WITH LENALIDOMIDE/ DEXAMETHASONE WITH PROPHYLAXIS

A Validated Stability-Indicating and Stereoselective HPLC Method for the Determination of Lenalidomide Enantiomers in Bulk Form and Capsules

CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel disease

EPT-16A PHASE 1 TRIAL OF LENALIDOMIDE PLUS RADIOTHERAPY IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMAS OR HIGH-GRADE GLIOMAS

 

More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics

GO

Show Summary Details

Quick Reference

n. a drug, related to thalidomide, that affects the immune response and has activity against tumour cell formation and angiogenesis. It is used to treat multiple myeloma and certain types of myelodysplastic syndromes. It is taken by mouth; the most serious side-effects are deep vein thrombosis and neutropenia, and there is a risk of teratogenesis (women capable of bearing children must practise contraception during treatment and for a month before and after it). Trade name: Revlimid.

Subjects: Clinical Pharmacology and Therapeutics.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.